SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
6.61
+0.92 (16.08%)
Aug 4, 2026, 2:29 PM EDT - Market open
SOPHiA GENETICS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 107.67 | 70.29 | 80.23 | 123.25 | 178.61 | 265.32 |
Cash & Short-Term Investments | 107.67 | 70.29 | 80.23 | 123.25 | 178.61 | 265.32 |
Cash Growth | 13.54% | -12.39% | -34.91% | -31.00% | -32.68% | 172.55% |
Inventory | 7.08 | 6.35 | 5.87 | 6.48 | 5.16 | 5.73 |
Other Current Assets | 8.43 | 7.44 | 5.88 | 4.76 | 5.84 | 5.53 |
Total Current Assets | 137.29 | 99.08 | 99.41 | 148.05 | 196.26 | 282.86 |
Net Property, Plant & Equipment | 15.94 | 18.05 | 19.38 | 23.1 | 21.4 | 15.96 |
Other Intangible Assets | 36.16 | 35.89 | 29 | 27.19 | 19.96 | 15.67 |
Other Long-Term Assets | 8.96 | 10.01 | 7.53 | 7.82 | 6.22 | 5.69 |
Total Assets | 198.36 | 163.03 | 155.31 | 206.16 | 243.84 | 320.17 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.9 | 8.96 | 5.22 | 5.39 | 6.18 | 6.74 |
Accrued Expenses | 18.7 | 20.74 | 13.22 | 17.81 | 14.51 | 15.97 |
Current Portion of Leases | 2.72 | 2.7 | 2.19 | 2.93 | 2.69 | 1.81 |
Unearned Revenue | 15.62 | 16.72 | 5.73 | 9.49 | 3.43 | 4.07 |
Other Current Liabilities | 2.14 | 1.41 | 0.44 | - | - | 0.01 |
Total Current Liabilities | 51.08 | 50.53 | 26.8 | 35.62 | 26.81 | 28.6 |
Long-Term Debt | 48 | 47.73 | 13.24 | - | - | - |
Long-Term Leases | 11.11 | 12.59 | 14.6 | 15.67 | 14.05 | 11.25 |
Other Long-Term Liabilities | 5.05 | 5.04 | 4.18 | 3.42 | 2.85 | 4.92 |
Total Long-Term Liabilities | 64.16 | 65.36 | 32.02 | 19.09 | 16.9 | 16.17 |
Total Liabilities | 115.24 | 115.89 | 58.82 | 54.71 | 43.71 | 44.77 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4.81 | 4.81 | 4.19 | 4.05 | 3.46 | 3.33 |
Treasury Stock | -0.18 | -1.22 | -0.7 | -0.65 | -0.12 | - |
Additional Paid-in Capital | 542.66 | 473.68 | 472.24 | 471.85 | 471.62 | 470.89 |
Accumulated Other Comprehensive Income | 96.78 | 89.15 | 61.04 | 53.98 | 23.96 | 12.54 |
Retained Earnings | -560.95 | -519.28 | -440.28 | -377.78 | -298.8 | -211.35 |
Shareholders' Equity | 83.12 | 47.15 | 96.49 | 151.44 | 200.13 | 275.4 |
Total Liabilities & Equity | 198.36 | 163.03 | 155.31 | 206.16 | 243.84 | 320.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 61.83 | 63.02 | 30.03 | 18.6 | 16.74 | 13.06 |
Net Cash (Debt) | 45.84 | 7.27 | 50.2 | 104.65 | 161.87 | 252.26 |
Net Cash Growth | 47.82% | -85.52% | -52.03% | -35.35% | -35.83% | 179.99% |
Net Cash Per Share | 0.65 | 0.11 | 0.76 | 1.62 | 2.52 | 4.56 |
Book Value | 83.12 | 47.15 | 96.49 | 151.44 | 200.13 | 275.4 |
Book Value Per Share | 1.18 | 0.70 | 1.46 | 2.34 | 3.12 | 4.98 |
Tangible Book Value | 46.96 | 11.25 | 67.49 | 124.26 | 180.17 | 259.73 |
Tangible Book Value Per Share | 0.67 | 0.17 | 1.02 | 1.92 | 2.81 | 4.70 |